Drug:
Reaction: ASTHMA
20260101 - 20261231
No. 1101 - 1200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1101 | 26762956 |
US |
17 | 1 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, |
||||
| 1102 | 26763597 |
US |
48 | 2 |
Fatigue, Nausea, Vomiting, Asthma, |
||||
EVOLOCUMAB, LEVOCETIRIZINE DIHYDROCHLORIDE, LUMATEPERONE, DEXLANSOPRAZOLE, ESCITALOPRAM, IPRATROPIUM BROMIDE, CLOPIDOGREL, MONTELUKAST SODIUM, LOSARTAN POTASSIUM, HYDROCORTISONE 2.5%, SPIRONOLACTONE, FUROSEMIDE, RIMEGEPANT SULFATE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, PROMETHAZINE HYDROCHLORIDE, ALBUTEROL SULFATE, LATANOPROST, NITROGLYCERIN, MELATONIN, CETIRIZINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 1103 | 26763661 |
US |
46 | 1 |
Asthma, Therapeutic response decreased, |
||||
DUPILUMAB, |
||||
| 1104 | 26763902 |
US |
63 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1105 | 26757524 |
US |
57 | 2 |
Cough, Fatigue, Asthma, Product dose omission issue, Dysphonia, Infection, |
||||
DUPILUMAB, |
||||
| 1106 | 26757536 |
US |
78 | 2 |
Asthma, Chronic obstructive pulmonary disease, Pruritus, |
||||
DUPILUMAB, |
||||
| 1107 | 26757663 |
US |
2 | |
Asthma, Condition aggravated, Intensive care, Ear infection, Hypersensitivity, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1108 | 26757696 |
US |
2 | |
Dyspnoea, Chest discomfort, Dry mouth, Blepharospasm, Insomnia, Asthma, Sinusitis, Thirst, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FREMANEZUMAB-VFRM, MONTELUKAST SODIUM, VORTIOXETINE, VALACYCLOVIR HYDROCHLORIDE, |
||||
| 1109 | 26757746 |
US |
73 | 2 |
Asthma, |
||||
EVOLOCUMAB, ALPRAZOLAM, EPINEPHRINE, ADRENALINUM, LEVALBUTEROL HYDROCHLORIDE, LEVALBUTEROL TARTRATE, MONTELUKAST SODIUM, MONTELUKAST, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CETIRIZINE HYDROCHLORIDE, |
||||
| 1110 | 26757973 |
US |
1 | |
Asthma, Illness, |
||||
DUPILUMAB, |
||||
| 1111 | 26758016 |
US |
2 | |
Pruritus, Dysphonia, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 1112 | 26758053 |
US |
2 | |
Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 1113 | 26758226 |
US |
2 | |
Pneumonia, Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1114 | 26758238 |
US |
53 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, IRON, SALMETEROL XINAFOATE, |
||||
| 1115 | 26758324 |
CA |
70 | 2 |
Asthma, Bladder disorder, Dyspnoea, Fall, Mobility decreased, Pelvic pain, |
||||
ZOLEDRONIC ACID, CLOPIDOGREL, CLOPIDOGREL BISULFATE, LANSOPRAZOLE, SERTRALINE, ERGOCALCIFEROL, |
||||
| 1116 | 26758388 |
US |
33 | 2 |
Off label use, Infection, Asthma, |
||||
OMALIZUMAB, OMALIZUMAB, TERIPARATIDE, |
||||
| 1117 | 26758628 |
US |
1 | |
Asthma, Quality of life decreased, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, DOXYCYCLINE, DOXYCYCLINE HYCLATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1118 | 26759112 |
US |
28 | 1 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1119 | 26759163 |
CA |
65 | 2 |
Asthma, Pneumonia, Wheezing, Drug hypersensitivity, Dyspnoea, Oedema, Vomiting, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RITUXIMAB, RITUXIMAB, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCIUM GLUCONATE, CALCIUM GLUCONATE, CLONAZEPAM, CLONAZEPAM, ROSUVASTATIN, FOLIC ACID, FOLIC ACID, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, TRAMADOL HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, |
||||
| 1120 | 26759409 |
US |
44 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1121 | 26759451 |
US |
61 | 2 |
Ear infection, Dry mouth, Vision blurred, Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALPRAZOLAM, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, FAMOTIDINE, FLUTICASONE PROPIONATE, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, MESALAMINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, ALBUTEROL SULFATE, ROSUVASTATIN, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIZANIDINE HYDROCHLORIDE, TORSEMIDE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 1122 | 26759820 |
US |
53 | 2 |
Asthma, Therapeutic response shortened, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1123 | 26759845 |
US |
2 | |
Hospitalisation, Rhinovirus infection, Asthma, |
||||
DUPILUMAB, |
||||
| 1124 | 26759854 |
US |
71 | 2 |
Muscle spasms, Dyspnoea, Asthma, Nasopharyngitis, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 1125 | 26760040 |
CA |
65 | 2 |
Asthma, Drug hypersensitivity, Dyspnoea, Oedema, Pneumonia, Vomiting, Wheezing, |
||||
AMLODIPINE BESYLATE, CIPROFLOXACIN HYDROCHLORIDE, MONTELUKAST, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, RISEDRONATE SODIUM, RITUXIMAB, ROSUVASTATIN, TRAMADOL HYDROCHLORIDE, THEOPHYLLINE, THEOPHYLLINE ANHYDROUS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLONAZEPAM, ERGOCALCIFEROL, FOLIC ACID, OMALIZUMAB, PREDNISONE, CALCIUM, ROSUVASTATIN, |
||||
| 1126 | 26760563 |
US |
43 | 2 |
Asthma, Injection site reaction, |
||||
DUPILUMAB, |
||||
| 1127 | 26760759 |
US |
32 | 2 |
Dyspnoea, Asthma, Incorrect dose administered by device, Product complaint, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 1128 | 26761277 |
US |
54 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1129 | 26761569 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1130 | 26761623 |
CN |
||
Asthma, Condition aggravated, Dyspnoea, C-reactive protein increased, |
||||
TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1131 | 26761856 |
CA |
76 | 2 |
Asthma, Type 2 diabetes mellitus, Hyperglycaemia, Full blood count abnormal, Gastrooesophageal reflux disease, |
||||
SITAGLIPTIN, SITAGLIPTIN, SITAGLIPTIN, SITAGLIPTIN, |
||||
| 1132 | 26761939 |
CA |
2 | |
Pneumonia, Influenza, Hernia, Asthma, COVID-19, |
||||
BENRALIZUMAB, BENRALIZUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, PREDNISONE, |
||||
| 1133 | 26761956 |
US |
28 | 2 |
Suicide attempt, Sjogren^s syndrome, Bipolar disorder, Breast cyst, Acne, Emotional distress, Acne cystic, Xerosis, Skin exfoliation, Dry skin, Scar, Epistaxis, Abdominal discomfort, Chapped lips, Anxiety, Actinic keratosis, Anaesthetic complication, Arthritis, Asthma, Depression, Folliculitis, Urticaria, Fibromyalgia, Haematuria, Keratosis pilaris, Dry eye, Borderline personality disorder, Injury, |
||||
ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, ISOTRETINOIN, |
||||
| 1134 | 26762036 |
US |
2 | |
Asthma, |
||||
DUPILUMAB, |
||||
| 1135 | 26762041 |
US |
39 | 2 |
Asthma, Dyspnoea, Inappropriate schedule of product administration, Nasal polypectomy, |
||||
DUPILUMAB, AMLODIPINE BESYLATE, FLUOXETINE HYDROCHLORIDE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE PROPIONATE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 1136 | 26752231 |
CN |
61 | 1 |
Asthma, Drug ineffective, |
||||
ALBUTEROL SULFATE, |
||||
| 1137 | 26752303 |
US |
||
Asthma, Therapy cessation, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 1138 | 26752390 |
US |
9 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1139 | 26752680 |
US |
66 | 2 |
Asthma, Respiratory tract congestion, Cough, Wheezing, |
||||
DUPILUMAB, |
||||
| 1140 | 26752854 |
US |
51 | 2 |
Influenza, Asthma, Rash erythematous, Skin warm, Rash, |
||||
DUPILUMAB, |
||||
| 1141 | 26752879 |
US |
67 | 2 |
Rash, Asthma, |
||||
DUPILUMAB, |
||||
| 1142 | 26752967 |
US |
2 | |
Asthma, |
||||
OMALIZUMAB, TRALOKINUMAB-LDRM, |
||||
| 1143 | 26753626 |
US |
65 | 2 |
Asthma, Cough, Wheezing, |
||||
DUPILUMAB, |
||||
| 1144 | 26753640 |
CA |
68 | 2 |
Illness, Asthma, Cough, Wheezing, Gastrooesophageal reflux disease, Viral infection, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, RABEPRAZOLE, RAMIPRIL, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, |
||||
| 1145 | 26753649 |
CA |
72 | 2 |
Lower respiratory tract infection, Chest pain, Dyspnoea, Fatigue, Cough, Secretion discharge, Asthma, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, ROSUVASTATIN, INDAPAMIDE, APIXABAN, BUPROPION, |
||||
| 1146 | 26753968 |
US |
45 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1147 | 26753981 |
US |
44 | 2 |
Asthma, Dyspnoea, Dyspnoea, Wheezing, Product dose omission in error, |
||||
DUPILUMAB, |
||||
| 1148 | 26753986 |
US |
27 | 2 |
Asthma, Product dose omission issue, Injection site swelling, |
||||
DUPILUMAB, |
||||
| 1149 | 26753993 |
US |
62 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALLOPURINOL, AMLODIPINE, ROSUVASTATIN, ATORVASTATIN CALCIUM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ORAL SEMAGLUTIDE, |
||||
| 1150 | 26754009 |
US |
60 | 1 |
Asthma, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 1151 | 26754280 |
US |
31 | 2 |
Asthma, Obesity, Immunosuppression, |
||||
OCRELIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE AND BUDESONIDE, ALPRAZOLAM, CETIRIZINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, SPIRONOLACTONE, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 1152 | 26754725 |
US |
2 | |
Asthma, Malaise, Paranasal sinus discomfort, Nasal congestion, |
||||
OMALIZUMAB, |
||||
| 1153 | 26754847 |
US |
42 | 2 |
Sinusitis, Condition aggravated, Influenza, Asthma, |
||||
DUPILUMAB, |
||||
| 1154 | 26755258 |
CA |
86 | 2 |
Asthma, Chronic obstructive pulmonary disease, Pulmonary oedema, Carbon dioxide increased, Dysphonia, |
||||
DUPILUMAB, DENOSUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CICLESONIDE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, PAROXETINE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE HEMIHYDRATE, MIRTAZAPINE, MIRTAZAPINE, MIRTAZAPINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 1155 | 26755264 |
US |
45 | 2 |
Dyspnoea, Asthma, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1156 | 26755282 |
US |
48 | 2 |
Asthma, Dyspnoea, Wheezing, Illness, |
||||
DUPILUMAB, |
||||
| 1157 | 26755302 |
US |
75 | 2 |
Pulmonary arterial hypertension, COVID-19, Asthma, Aspiration, Cardiac failure, Joint swelling, Genital pain, |
||||
DUPILUMAB, ALBUTEROL SULFATE, GABAPENTIN, GABAPENTIN, BECLOMETHASONE DIPROPIONATE HFA, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, SPIRONOLACTONE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TADALAFIL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, CARVEDILOL, BUMETANIDE, TEZEPELUMAB-EKKO, |
||||
| 1158 | 26755619 |
US |
45 | 2 |
Back pain, Arthralgia, Asthma, |
||||
DUPILUMAB, |
||||
| 1159 | 26755641 |
US |
74 | 1 |
Asthma, Nasal congestion, Lacrimation increased, Cough, Dyspnoea, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 1160 | 26756826 |
EU |
56 | 1 |
Allergic bronchitis, Asthma, |
||||
LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 1161 | 26756974 |
US |
75 | 1 |
Shoulder operation, Asthma, Hypersensitivity, Bronchitis, |
||||
EVOLOCUMAB, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, ALBUTEROL, TIOTROPIUM BROMIDE, ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 1162 | 26757016 |
GB |
63 | 2 |
Asthma, |
||||
HYDROCORTISONE BUTYRATE, |
||||
| 1163 | 26757305 |
US |
42 | 2 |
Asthma, Drug ineffective, |
||||
DUPILUMAB, CYANOCOBALAMIN, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, NORETHINDRONE, FAMOTIDINE, LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 1164 | 26747082 |
CO |
61 | 2 |
Immunosuppression, Asthma, Influenza, |
||||
GOLIMUMAB, |
||||
| 1165 | 26747142 |
US |
2 | |
Pneumonia, Asthma, Fall, Cerebral haemorrhage, Hand fracture, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1166 | 26747222 |
US |
56 | 2 |
Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, CYCLOBENZAPRINE, MONTELUKAST, PANTOPRAZOLE, PREDNISONE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 1167 | 26747234 |
US |
50 | 1 |
Asthma, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1168 | 26747262 |
EU |
||
Off label use, Anaphylactic reaction, Urticaria, Oral pruritus, Asthma, |
||||
IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 1169 | 26747350 |
CA |
79 | 2 |
Pneumonia, Cardiac failure congestive, Lower respiratory tract infection, Asthma, |
||||
ALBUTEROL SULFATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, TIOTROPIUM BROMIDE INHALATION SPRAY, MONTELUKAST SODIUM, |
||||
| 1170 | 26747908 |
US |
2 | |
Asthma, Product delivery mechanism issue, Multiple allergies, |
||||
CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN, |
||||
| 1171 | 26747937 |
CA |
78 | 2 |
Pelvic fracture, Asthma, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, |
||||
| 1172 | 26748167 |
CA |
82 | 2 |
Urinary tract infection, Hospitalisation, Furuncle, Erythema, Vaginal prolapse, Condition aggravated, Gait disturbance, Intestinal prolapse, Cystocele, Genital haemorrhage, Injection site pruritus, Injection site swelling, Injection site pain, Injection site erythema, Off label use, Gastrointestinal disorder, Illness, Injection site urticaria, Malaise, Post procedural haemorrhage, Urethral prolapse, Cognitive disorder, Pain, Asthma, Vaginal haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, CICLESONIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, |
||||
| 1173 | 26748181 |
US |
38 | 2 |
Rheumatoid arthritis, Pain, Cough, Asthma, |
||||
DUPILUMAB, |
||||
| 1174 | 26748282 |
US |
1 | |
Asthma, |
||||
UPADACITINIB, |
||||
| 1175 | 26748415 |
US |
1 | |
Asthma, Incorrect dose administered by device, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 1176 | 26748674 |
US |
1 | |
Pulmonary embolism, Deep vein thrombosis, Oxygen saturation decreased, Pruritus, Asthma, Fatigue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 1177 | 26749527 |
CA |
83 | 1 |
Asthenia, Asthma, Cardiac disorder, Dyspnoea, Dyspnoea exertional, Dysuria, Hypokalaemia, Heart rate irregular, Illness, Lower respiratory tract infection, Muscular weakness, Pneumonia, Nasal congestion, Productive cough, X-ray abnormal, Dizziness, Malaise, Inappropriate schedule of product administration, |
||||
MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FUROSEMIDE, ALBUTEROL SULFATE, |
||||
| 1178 | 26749760 |
15 | ||
Asthma, Drug dose omission by device, Device delivery system issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, |
||||
| 1179 | 26749933 |
CA |
57 | 1 |
Haematological infection, Asthma, Inflammation, Pyrexia, Oxygen saturation decreased, Heart rate irregular, Therapy cessation, |
||||
BENRALIZUMAB, BENRALIZUMAB, ALBUTEROL SULFATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 1180 | 26750296 |
US |
61 | 2 |
Illness, Asthma, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1181 | 26750561 |
US |
16 | 1 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1182 | 26751156 |
US |
59 | 2 |
Rhinitis, Asthma, |
||||
DUPILUMAB, |
||||
| 1183 | 26751160 |
US |
56 | 2 |
Asthma, Gastrooesophageal reflux disease, Oropharyngeal pain, Dysphonia, |
||||
DUPILUMAB, |
||||
| 1184 | 26751299 |
EU |
61 | 2 |
Acute kidney injury, Creatine kinase increased, Asthma, |
||||
RESLIZUMAB, MONTELUKAST, TIOTROPIUM BROMIDE, QUETIAPINE, SERTRALINE, |
||||
| 1185 | 26751422 |
US |
2 | |
Asthma, Product dose omission issue, Eczema, |
||||
DUPILUMAB, |
||||
| 1186 | 26751712 |
CA |
1 | |
Pneumothorax, Productive cough, Headache, Asthma, Drug ineffective, |
||||
CICLESONIDE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 1187 | 26751733 |
US |
2 | |
Chronic obstructive pulmonary disease, Asthma, |
||||
DUPILUMAB, |
||||
| 1188 | 26751922 |
US |
74 | 2 |
Asthma, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1189 | 26751929 |
US |
58 | 2 |
Asthma, |
||||
DUPILUMAB, ACARBOSE, FREMANEZUMAB-VFRM, ALPRAZOLAM, ONABOTULINUMTOXINA, ONABOTULINUMTOXINA, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUPROPION, BUTALBITAL AND ACETAMINOPHEN, BUTALBITAL AND ACETAMINOPHEN TABLETS, CLARITHROMYCIN, CYCLOBENZAPRINE, |
||||
| 1190 | 26752127 |
US |
71 | 2 |
Asthma, Head discomfort, Confusional state, |
||||
INSULIN ASPART INJECTION, INSULIN ASPART, |
||||
| 1191 | 26741360 |
US |
33 | 2 |
Asthma, Rash erythematous, Miliaria, Dermatitis, Eyelid disorder, Eyelid margin crusting, Eczema, |
||||
DUPILUMAB, |
||||
| 1192 | 26741376 |
US |
52 | 2 |
Asthma, |
||||
DUPILUMAB, |
||||
| 1193 | 26741810 |
US |
42 | 2 |
Asthma, Chest discomfort, Dyspnoea, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 1194 | 26741828 |
US |
2 | |
Asthma, Product dose omission issue, Wheezing, |
||||
DUPILUMAB, |
||||
| 1195 | 26741829 |
US |
77 | 1 |
Asthma, Sleep disorder due to a general medical condition, |
||||
DUPILUMAB, |
||||
| 1196 | 26742115 |
US |
2 | |
Pruritus, Eye pruritus, Dry eye, Asthma, |
||||
DUPILUMAB, ALBUTEROL SULFATE, CELECOXIB, CERTOLIZUMAB PEGOL, LORATADINE, LORATADINE TABLET, VALSARTAN, DULOXETINE HYDROCHLORIDE, DULOXETINE, EPINEPHRINE, ADRENALINUM, FLUTICASONE PROPIONATE, FOLIC ACID, METHOTREXATE SODIUM, MONTELUKAST SODIUM, MONTELUKAST, EPINEPHRINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, PREGABALIN, ALBUTEROL SULFATE, DENOSUMAB, ROSUVASTATIN CALCIUM, VITAMIN C, FLUTICASONE PROPIONATE AND SALMETEROL, ALPRAZOLAM, |
||||
| 1197 | 26742137 |
US |
2 | |
Anxiety, Asthma, Wrong technique in device usage process, Incorrect dose administered, |
||||
ALBUTEROL SULFATE, |
||||
| 1198 | 26742597 |
US |
2 | |
Asthma, Urticaria, |
||||
DUPILUMAB, OMALIZUMAB, |
||||
| 1199 | 26742723 |
EU |
24 | 1 |
Pulmonary congestion, Asthma, Dysphonia, Productive cough, Breath sounds abnormal, Snoring, Muscle spasms, Fatigue, Product use issue, Product appearance confusion, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, TIOTROPIUM BROMIDE, LOSARTAN, |
||||
| 1200 | 26742921 |
US |
65 | 2 |
Injection site pain, Asthma, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30